Table: Stella Pharma - 9-MTH parent results

Stella Pharma

12/02/2026 05:01

Feb 12 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2025        Dec 31, 2024      Mar 31, 2026  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            261 mln             254 mln           377 mln    
                 (+3.0 pct)          (+26.9 pct)       (-60.7 pct)  
  Operating     loss 512 mln        loss 375 mln      loss 922 mln  
  Recurring     loss 509 mln        loss 371 mln      loss 908 mln  
  Net           loss 512 mln        loss 373 mln      loss 911 mln  
  EPS          loss 15.05 yen      loss 11.27 yen    loss 26.80 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T